Presenter
Biography
I am currently pursuing a PhD (2nd year) at the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, Canada. My academic journey began with obtaining my Bachelor's degree in Pharmacy from the Faculty of Pharmacy at Alexandria University, Egypt. This foundation has led me to delve deeper into the field of pharmacokinetics, particularly focusing on neurocritically ill patients.
My research is centered on the phenomenon of augmented renal clearance (ARC) in neurocritically ill patients. ARC can significantly alter drug pharmacokinetics, leading to suboptimal drug dosing and potentially impacting patient outcomes. My work aims to understand the prevalence of ARC within this specific patient population, unravel the underlying pathogenesis of this phenomenon, and assess its effects on the pharmacokinetics of selected medications that are frequently administered to neurocritically ill patients.
I have been fortunate to receive eight different awards during my academic career, which recognize both my research and academic achievements. Among these honors, I am particularly proud of being awarded the prestigious Alberta Innovates Scholarship, which supports innovative research in Alberta. My work has also been acknowledged through multiple best presentation awards at various conferences and symposiums, reflecting the significance and impact of my research findings.
In addition to my research, I am passionate about contributing to the academic community and advancing the field of pharmaceutical sciences. I actively participate in conferences, symposiums, and other academic forums where I share my research findings and engage with fellow researchers and professionals.
My ultimate goal is to improve drug dosing guidelines and therapeutic outcomes for neurocritically ill patients by providing evidence-based recommendations. Through my research, I hope to make a meaningful contribution to the field of pharmacotherapy and enhance the quality of care for this vulnerable patient population.
My research is centered on the phenomenon of augmented renal clearance (ARC) in neurocritically ill patients. ARC can significantly alter drug pharmacokinetics, leading to suboptimal drug dosing and potentially impacting patient outcomes. My work aims to understand the prevalence of ARC within this specific patient population, unravel the underlying pathogenesis of this phenomenon, and assess its effects on the pharmacokinetics of selected medications that are frequently administered to neurocritically ill patients.
I have been fortunate to receive eight different awards during my academic career, which recognize both my research and academic achievements. Among these honors, I am particularly proud of being awarded the prestigious Alberta Innovates Scholarship, which supports innovative research in Alberta. My work has also been acknowledged through multiple best presentation awards at various conferences and symposiums, reflecting the significance and impact of my research findings.
In addition to my research, I am passionate about contributing to the academic community and advancing the field of pharmaceutical sciences. I actively participate in conferences, symposiums, and other academic forums where I share my research findings and engage with fellow researchers and professionals.
My ultimate goal is to improve drug dosing guidelines and therapeutic outcomes for neurocritically ill patients by providing evidence-based recommendations. Through my research, I hope to make a meaningful contribution to the field of pharmacotherapy and enhance the quality of care for this vulnerable patient population.
Presentations
Abstract
Science of Neurocritical Care
Medical Issues, Pharmacology, and Coagulopathy
Intermediate